Nutrilead's Novel Immune Ingredient, BeniCaros ® Receives No Questions from FDA on GRAS Declaration

WAGENINGEN, Netherlands, April 21, 2022 /PRNewswire-PRWeb/ -- Nutrileads has received a letter with no questions from the United States Food and Drug Administration (FDA) regarding their Generally Recognized as Safe (GRAS) application for their revolutionary immune health ingredient, BeniCaros®. The FDA letter states that the agency has no questions to Nutrileads application for GRAS status for BeniCaros® for inclusion in Dietary Supplements, Beverages, and Functional Foods.